We read with interest the study by Shippam et al. [1] regarding high-flow humidified nasal oxygen (HFNO) for pre-oxygenation of pregnant women in preparation for general anaesthesia. The findings from this study do not support the use of HFNO to pre-oxygenate term pregnant women. The primary end-point used was an end-tidal oxygen fraction (F ET O 2 ) ≥ 0.9 which is a recommended target for pre-oxygenation by the Obstetric Anaesthetists' Association [2] and the Difficult Airway Society. However, with the advancement in the use of HFNO as an adjunct in both pre-oxygenation and apnoeic oxygenation, should this target be revised? The use of HFNO maximises the physiological phenomenon of aventilatory mass flow, driving oxygen into the lungs and flushing out other dead space gases present [3]. This, coupled with the splinting of upper airways and reduction in associated shunt, can improve oxygenation [3].If this is the case, then is it a prerequisite to preoxygenate to a value of F ET O 2 ≥ 0.9 in a situation where we can continually replenish our oxygen stores via continuous HFNO? If the patency of the airway can be maintained can HNFO redefine our end-point for pre-oxygenation?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.